Share on StockTwits

EnteroMedics (NASDAQ:ETRM) posted its quarterly earnings results on Thursday. The company reported ($0.11) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.10) by $0.01, Stock Ratings Network.com reports.

Several analysts have recently commented on the stock. Analysts at Roth Capital raised their price target on shares of EnteroMedics from $3.00 to $5.00 in a research note on Wednesday, June 18th. They now have a “buy” rating on the stock. Analysts at Canaccord Genuity raised their price target on shares of EnteroMedics to $5.00 in a research note on Monday, June 16th. They now have a “buy” rating on the stock. Five research analysts have rated the stock with a buy rating, The stock presently has a consensus rating of “Buy” and an average price target of $5.20.

Shares of EnteroMedics (NASDAQ:ETRM) traded down 0.60% on Thursday, hitting $1.3121. 968,127 shares of the company’s stock traded hands. EnteroMedics has a one year low of $1.00 and a one year high of $2.66. The stock has a 50-day moving average of $1.52 and a 200-day moving average of $1.87. The company’s market cap is $88.2 million.

EnteroMedics Inc (NASDAQ:ETRM) is a development- stage medical device company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.